Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers
Impaired glucose homeostasis is one of the risk factors for causing metabolic diseases including obesity, type 2 diabetes, and cancers. In glucose metabolism, pyruvate dehydrogenase complex (PDC) mediates a major regulatory step, an irreversible reaction of oxidative decarboxylation of pyruvate to a...
Main Author: | Nam Ho Jeoung |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2015-06-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-188.pdf |
Similar Items
-
Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α
by: Nives Škorja Milić, et al.
Published: (2021-08-01) -
The Role of Pyruvate Dehydrogenase Kinase in Diabetes and Obesity
by: In-Kyu Lee
Published: (2014-06-01) -
Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy
by: Hunter C. Jonus, et al.
Published: (2020-01-01) -
Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases
by: Xiaoli Zhou, et al.
Published: (2016-03-01) -
Pyruvate dehydrogenase kinase inhibition: Reversing the Warburg effect in cancer therapy
by: Hayden Bell, et al.
Published: (2016-06-01)